Does THROMBOMODULIN ALFA Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with THROMBOMODULIN ALFA. This represents 15.3% of all adverse event reports for THROMBOMODULIN ALFA.
11
Reports of Off label use with THROMBOMODULIN ALFA
15.3%
of all THROMBOMODULIN ALFA reports
6
Deaths
3
Hospitalizations
How Dangerous Is Off label use From THROMBOMODULIN ALFA?
Of the 11 reports, 6 (54.5%) resulted in death, 3 (27.3%) required hospitalization, and 3 (27.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THROMBOMODULIN ALFA. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does THROMBOMODULIN ALFA Cause?
Drug ineffective (15)
Thrombotic microangiopathy (11)
Disseminated intravascular coagulation (9)
Blood alkaline phosphatase increased (7)
Blood creatinine increased (7)
Blood urea increased (7)
Cardiac failure acute (7)
Gamma-glutamyltransferase increased (7)
Weight increased (7)
Diarrhoea (6)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)